Showing results (2381-2390 of 3,440) with videos related to

Sort By:
Pageof 344
JAMA Pediatrics|October 15, 2019
Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical TrialKevin M Gray, Nathaniel L Baker, Erin A McClure, et al.
Journal of Epidemiology and Community Health|April 10, 2019
Associations between adult height and type 2 diabetes mellitus: a systematic review and meta-analysis of observational studiesSarita Shrestha, Sara H Rasmussen, Anton Pottegård, et al.
Current Medical Research and Opinion|May 24, 2019
Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patientsAmol D Dhamane, Christine L Baker, Jigar Rajpura, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 10, 2000
A new anatomical landmark for reliable identification of human area V5/MT: a quantitative analysis of sulcal patterningS O Dumoulin, R G Bittar, N J Kabani, et al.
Molecular Pharmacology|September 20, 2001
Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptorsD J Fischer, N Nusser, T Virag, et al.
American Journal of Obstetrics and Gynecology|October 8, 2019
Lower antimüllerian hormone is associated with lower oocyte yield but not live-birth rate among women with obesityWendy Vitek, Fangbai Sun, Valerie L Baker, et al.
Annals of Internal Medicine|January 19, 2011
Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidenceWilliam L Baker, Jennifer A Colby, Vanita Tongbram, et al.
Plos One|December 3, 2010
Birth weight, childhood body mass index and risk of coronary heart disease in adults: combined historical cohort studiesLise Geisler Andersen, Lars Angquist, Johan G Eriksson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Engineering actin-resistant human DNase I for treatment of cystic fibrosisJ S Ulmer, A Herzka, K J Toy, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 1, 1994
Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damageR T Bartus, K L Baker, A D Heiser, et al.
Pageof 344